AKT1 and central nervous system cancer: The m1A methyltransferase TRMT6 may contribute to glioma progression by modulating the cell cycle and affecting various pathways, including the PI3K-AKT, TGF-β, mTORC1, NOTCH, and MYC pathways [131].